Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

MMineralys Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
M

Mineralys Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
    Sep 24, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026
    Sep 23, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    Sep 21, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    Sep 9, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
    Aug 26, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
    Aug 13, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    Aug 11, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026
    Aug 4, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    Jul 27, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
    Jun 14, 2026Mineralys Therapeutics, Inc. (MLYS) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions